May 2011


CLAO has completed an exciting redesign on both its web sites ( and  You may access either site by typing “Contact Lens Doctors” in your favorite search engine, e.g., Google, Bing, etc., or by visiting either URL directly, (e.g., 

One of the major new changes is that some areas within the site are accessible by members only.  To access these member-only areas you will need to click on the login in the upper right hand corner of the site.  Two boxes will appear, one requesting a user name and the second box requesting a password.   

Your user name is the first letter of your first name followed by your full last name, e.g, Dr. John Smith’s user name would be jsmith.  When logging in for the first time, you will need to click password reminder to obtain a password.  This password will be automatically generated by the website system and sent to your email address that CLAO has on file for you.  Now that you have your user name and password, you will be able to access these member-only areas at will.   

President Michael H. Goldstein, MD, MBA states “CLAO is delighted to provide its members with a state-of-the-art internet site that provides for significantly expanded information and the ability for member input.  The value of the website improves with your input so please let CLAO know what you think about the update and recommend ways the sites can be made even more useful to you.  The more useful the information on the website is, the better the resource. We need your help to make it great!” 


CLAO and the CLAO Education and Research Foundation are partnering to present a major contact lens educational meeting.  This Symposium and Congress will be held January 26 – 28, 2012 at Caesars Palace Hotel in Las Vegas, Nevada.  Mark your calendar now for this special event.  Additional information on the meeting will soon be available on the CLAO web site.

Ophthalmologists preparing for board certification or re-certification will find several excellent Board Reviews at the Ophthalmology Board Reviews section of, .
Ophthalmologists completing CME requirements will find additional CME activities on the Ophthalmology Page,,, now has links to more than 325 Online CME sites offering more than 16,000 CME courses and more than 26,000 hours of CME credit in over 50 medical areas. The List is updated regularly as new online CME sites and courses become available. There is no charge for accessing the List and no registration is required.'



The World Ophthalmology Congress® will take place in Abu Dhabi, United Arab Emirates, from February 16 – 20, 2012. In numerous lectures, presentations, courses, posters and videos, leading experts of all subspecialties in ophthalmology will present the latest scientific knowledge and state of the art research in the field.  Abstracts can be submitted in one of the following categories:  Free Papers, Poster, Videos, Instruction Course.   Abstract submission deadline is June 1, 2011 and notification on abstract submission to the first author will be July 15, 2011.  The deadline for all presenters to be registered for the WOC is August 30, 2011  Submission guidelines are available online at:  For inquiries relating to the online abstract submission module, please contact Ms Manuela Marchetti, Meeting Minds-Experts,


Information in this section has been provided to CLAO by press releases and other means. CLAO does not warranty its accuracy; nor does notice of a product in this section constitute an endorsement by CLAO. 

Alcon Laboratories, Inc. sponsored an article on wettabiliy entitled “Why it matters, what works and what doesn’t work.”  This article may be viewed at:  In other news, the company noted that it presented data on a new wetting agent at the Association for Research and Vision in Ophthalmology (ARVO) annual meeting in May 2010. This wetting agent is a scientifically advanced synthetic block copolymer that uses proprietary polymer chemistry, EOBO, poly (oxyethylene)-poly (oxybutylene), and is designed for improving wettability properties of silicone hydrogel contact lenses.  The poster presentation at ARVO indicated that a test solution containing EOBO reduced the surface and bulk hydrophobicity and improved the hydrophilic properties of silicone hydrogel lenses as compared to a saline solution control. EOBO has an extremely high affinity for the hydrophobic areas of silicone hydrogel contact lenses and targets sites on and in the lens to retain moisture. “Silicone hydrogel lenses have undergone tremendous advances in the past 10 years and the EOBO wetting agent was designed to address the need for advanced technologies to help improve the performance of these lenses through improving the surface moisture,” says Howard Ketelson, Ph. D., Alcon’s director of Consumer Product Research. “Polyethylene oxide is the hydrophilic portion of the molecule and carries water efficiently and effectively to the hydrophobic lens sites that are not wetted by the tear film.”  Alcon is developing the EOBO technology specifically for silicone hydrogel contact lenses and is exploring further development to provide this benefit in Alcon’s contact lens care product line.

 Alden Optical’s Phoenix Program offers eye care practitioners a simple solution to the problem of discontinued vial sphere lenses. Our unique blend of custom manufacturing, broad parameter ranges, and multiple lens material options means the company is able to provide practitioners with Alden HP or Alden Classic lenses that are an extremely close substitute for many popular, but discontinued, sphere lenses.  For a complete listing of the discontinued and "on hold" brands that Alden is ready to replicate, follow the link below and click on "Phoenix Conversion Chart"

The American Medical Association (AMA) offers e-mail alerts on practice management and payer news.   Signing up for the AMA Practice Management Alerts is easy. Just visit and click the "Sign up" button.

Bausch & Lomb announced on January 28, 2011 a global licensing agreement with U.K.-based UltraVision CLPL to market and sell KeraSoft® soft contact lenses throughout the world, through the network of Bausch & Lomb lab channel partners. KeraSoft patented technology allows for custom-made contact lenses for irregular corneas and keratoconus. As part of the agreement, Bausch & Lomb acquired the KeraSoft trademark.The announcement was made at the Global Specialty Lens Symposium in Las Vegas. The global roll-out of KeraSoft lenses will begin later this year and will be executed around the world in phases.  “This technology has totally transformed my view of contact lens management of keratoconus and irregular cornea patients. The visual results and enhancement of life are true advances,” said Joseph Barr, O.D., M.S., F.A.A.O., vice president, Global Clinical & Medical Affairs and Professional Services, Vision Care, Bausch & Lomb.  Each KeraSoft contact lens is custom made for the patient’s exact needs, making it an ideal fit for manufacture and distribution through the Bausch & Lomb custom lab channel network. By utilizing Bausch & Lomb distribution channels throughout the world, Bausch & Lomb and UltraVision plan to significantly increase the number of patients who are able to benefit from customized KeraSoft contact lenses.  Irregular corneas can be caused by a number of reasons including disease, trauma, corneal transplants and complicated laser surgery. Such patients can have considerably reduced vision that is not adequately addressed by standard contact lenses. Traditionally, patients with irregular corneas have been limited to hard or rigid gas permeable lenses which resulted in reduced wear time for some patients. KeraSoft lenses can increase wearing time for some of these patients.  KeraSoft lenses, which are recognized with the U.K.’s Queen’s Award for Enterprise and Innovation, are a patented combination of the latest technologies in soft and silicone hydrogel materials using geometries from complex mathematics to offer comfortable wear and excellent vision.  In other news, the company announced on March 24, 2011 the appointment of David Mordaunt, Ph.D. as vice president, Development and Research, Bausch + Lomb Surgical.  In this position, Dr. Mordaunt will be a member of the Surgical senior leadership team and will be responsible for global strategies and execution of development and research programs for the full portfolio of products. Dr. Mordaunt is a recognized expert in the medical device industry for the development of innovative technologies that have changed the standard of patient care. These technologies include Pattern Scanning Laser (PASCAL) for diabetic retinopathy, Selective Laser Trabeculoplasty (SLT) for glaucoma and Photodynamic Therapy (PDT) for macular degeneration.  Dr. Mordaunt will be based in Aliso Viejo, California. 

The National Institutes of Health has expanded a genetic and clinical research database to give researchers access to the first digital study images. The National Eye Institute (NEI), in collaboration with the National Center for Biotechnology Information (NCBI), has made available more than 72,000 lens photographs and fundus photographs of the back of the eye, collected from the participants of the Age-Related Eye Disease Study (AREDS).

Novartis announced in a press release that it has completed its merger with Alcon. Stuart Raetzman.  In another press release from Alcon, Area President US and Vice President Global Marketing stated: “We are very pleased that Novartis and Alcon have closed the merger, uniting the strengths of Alcon, CIBA VISION and Novartis Ophthalmics into one eye care business.  We believe our combined leadership in eye care, our complementary product portfolios across surgical, pharmaceutical and vision care, as well as our expanded geographic reach will generate incremental growth and additional benefits for all our customers and their patients.  As we integrate the CIBA VISION operations and the Novartis Ophthalmics portfolio into the new Alcon Division as part of Novartis, our primary objective is to maintain our service and support to our customers. Please note that until our combined commercial operations go live in the second half of the year, we anticipate no change in our interactions with you.  Please continue to contact your respective Alcon or CIBA VISION sales and technical service representatives.” 

Vistakon, Division of Johnson & Johnson Vision Care, Inc. on February 2, 2011 in a press release stated that even though eye care doctors and manufacturers provide instructions about caring for and wearing contact lenses, studies show that many contact lens wearers do not comply with the recommended replacement frequencies and fail to discard their lenses after the scheduled time.  Forgetting which day to change their contacts is most commonly cited by wearers as the reason for not changing them as instructed. However, according to a new survey of contact lens wearers, ACUMINDERTM, a complimentary online reminder tool, is helping them change their behavior.  Since its launch in 2007, nearly 40,000 contact lens wearers have registered for the free service ( which sends an automatic reminder via e-mail and/or cell phone text message on when to change contact lenses, and can now also prompt wearers on when to buy new contacts  and when to schedule an eye exam.   The ACUMINDERTM Tool was developed by VISTAKON®, Division of Johnson & Johnson Vision Care, Inc. and maker of ACUVUE® Brand Contact Lenses, but is open to all contact lens wearers.   Nearly 700 ACUMINDERTM users recently responded to a questionnaire about their contact lens wearing habits. Virtually all (95 percent) said they find the reminder tool useful in helping them remember when to change their lenses, with two-thirds (66 percent) noting that it has improved their contact lens replacement.  Prior to enrolling in ACUMINDERTM, 40 percent of survey respondents who wear two-week lenses self-reported that they changed their lenses at or less than every 14 days (average wear time: 19.9 days), Since using the reminder, 76 percent  say they now change their lenses at or less than every 14 days (average days worn = 14.7).


The 2012 CLAO/CLAO ERF Symposium and Congress will be held in Las Vegas, Nevada on January 26 through 28, 2012.  
For more information visit  

The 2011 American Academy of Ophthalmology (AAO) Annual Meeting is scheduled for October 22–25, in Orlando, FL.  JCAHPO holds its annual ACE meeting in conjunction with the AAO.

 The 2011 Japan Contact Lens Society (JCLS) Annual Meeting is scheduled for July 9–10 in Kyoto, Japan.

 The 41st ECLSO Annual Meeting will be held in Istanbul, Turkey on September 9 – 11.  For more information visit

 The XXXVI Brazilian Ophthalmology Congress will be taking place in Porto Alegre at Fiergs Convention Center, from September 05th to 08th, 2011.

The EuroKeratoConus II Meeting is scheduled for September 22 – 24, 2011 in Bordeaux, France.  Abstract submissions are welcome through June 30th and should be sent to  welcome through  Registration is available online at or

The World Ophthalmology Congress will be held in Abu Dhabi, UAE, February 16 to 20, 2012.  For more information visit

CLAO “Did You Know?”:

CLAO’s new web site includes a clinical photos section and that members are welcome to submit photos for placement in this section?


For Your Amusement

Seniors Having Fun:

Working people frequently ask retired people what they do to make their days interesting.  Well, for example, the other day, Mary my wife and I went
 into town and visited a shop.  When we came out, there was a policeman writing out a parking ticket.  We went up to him and I said, 'Come on, sir, 
how about giving a senior citizen a break?'  He completely ignored us and continued writing the ticket.  I kept after him upon which he glared at me 
and started writing another ticket for having worn-out tires.  So Mary called him a “gutless toad.”  He finished the second ticket and put it on the windshield with the first.  Then he started writing more tickets.  This went on for about 20 minutes, as the more fun we poked at him, the more 
tickets he wrote.  Just then our bus arrived, and we got on it and went home as the befuddled policeman looked on in disbelief.  We try to have 
a little fun each day now that we're retired.  It's important at our age.


Contact Lens Event Reporting:

To report adverse contact lens reactions: or call (800) FDA-1088.

 To report possible grievances related to the Fairness to Contact Lens Consumers Act or the associated Contact Lens Rule:

Contact CLAO:

CLAO, 2025 Woodlane Drive, Saint Paul, MN, 55125

Phone:  877-501-EYES (3937)   Fax:  651-731-0410  Email: 

Web:, and